DBV Technologies | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amarin USD 553.15M 15.98M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Insmed USD -331923000 42.57M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12



DBV Technologies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.